Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1987-2-3
pubmed:abstractText
Human granulocyte-macrophage colony stimulating factor (GM-CSF) has been synthesized in high yield using a temperature inducible plasmid in Escherichia coli. The human GM-CSF is readily isolated from the bacterial proteins because of its differential solubility and chromatographic properties. The bacterially synthesized form of the human GM-CSF contains an extra methionine residue at position 1, but otherwise it is identical to the polypeptide predicted from the cDNA sequence. The specific activity of 2.9 X 10(7) units/mg of protein for purified bacterially synthesized human GM-CSF indicates that despite the lack of glycosylation, the molecule is substantially in its native conformation. This molecule stimulated the same number and type of both seven- and 14-day human bone marrow colonies as the CSF alpha preparation from human placental conditioned medium. Human GM-CSF had no activity on murine bone marrow or murine leukemic cells. There was no detectable, direct stimulation of adult human erythroid burst forming units (BFU-E) by the bacterially synthesized human GM-CSF. Although impure preparations containing native human GM-CSF (eg, human placental conditioned medium) stimulated the formation of mixed colonies, even in the presence of erythropoietin, the bacterially synthesized human GM-CSF failed to stimulate the formation of mixed colonies from adult human bone marrow cells. The bacterially synthesized human GM-CSF increased N-formyl-methionyl-leucyl-phenylalanine (FMLP)-induced superoxide production and lysozyme secretion. Antibody-dependent cytotoxicity and phagocytosis by human neutrophils was stimulated by the bacterially synthesized human GM-CSF and eosinophils were also activated in the antibody-dependent cytotoxicity assay.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
43-51
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:3024761-Antibody-Dependent Cell Cytotoxicity, pubmed-meshheading:3024761-Bone Marrow Cells, pubmed-meshheading:3024761-Cell Division, pubmed-meshheading:3024761-Chromatography, High Pressure Liquid, pubmed-meshheading:3024761-Erythropoiesis, pubmed-meshheading:3024761-Erythropoietin, pubmed-meshheading:3024761-Escherichia coli, pubmed-meshheading:3024761-Granulocytes, pubmed-meshheading:3024761-Hematopoiesis, pubmed-meshheading:3024761-Hematopoietic Stem Cells, pubmed-meshheading:3024761-Humans, pubmed-meshheading:3024761-Interleukin-3, pubmed-meshheading:3024761-Molecular Weight, pubmed-meshheading:3024761-Muramidase, pubmed-meshheading:3024761-Phagocytosis, pubmed-meshheading:3024761-Promoter Regions, Genetic, pubmed-meshheading:3024761-Recombinant Proteins, pubmed-meshheading:3024761-Superoxides
pubmed:year
1987
pubmed:articleTitle
Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't